Photodermatosis associated with eculizumab (Soliris): a novel monoclonal antibody directed against the complement protein C5.
Yevgeniy
Y
Balagula
Steven B
SB
Newman
Mario E
ME
Lacouture
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003182:Complement C5 / Q000037:antagonists & inhibitors*; D005260:Female; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy*; D006801:Humans; D010787:Photosensitivity Disorders / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003182:Complement C5; C481642:eculizumab